Predicting resistance to anticancer drugs

(VIB (the Flanders Institute for Biotechnology)) Cancer cells can develop resistance to therapy through both genetic and non-genetic mechanisms. But it is unclear how and why one of these routes to resistance prevails. Understanding this 'choice' by the cancer cells may help us devise better therapeutic strategies. Now, the team of Prof. Jean-Christophe Marine (VIB-KU Leuven Center for Cancer Biology) shows that the presence of certain stem cells correlates with the development of nongenetic resistance mechanisms.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news